Stock acquisition rights for officers conditional on EBITDA exceeding ¥2 billion
First written in FY2017-Q1. 4 of 12 entries say "Raised", first in FY2018-Q1. Latest entry: 2026-09-24.
29 other companies' latest entry also says "Advanced".
- FY2026RaisedAnnual report
「Holders of the stock acquisition rights may exercise them thereafter only if operating income stated in the company's consolidated statements of income exceeds ¥5,500 million in any fiscal year from the fiscal year ending March 2029 through the fiscal year ending March 2031.」
For the new stock acquisition rights issued in November 2025, the company set a condition that operating income exceed ¥5.5 billion in any fiscal year from the fiscal year ending March 2029 through the fiscal year ending March 2031. This is higher than the previous ¥4 billion operating income condition. - FY2021RestatedAnnual report
「If operating income exceeded ¥4,000 million in any fiscal year ending March 2020, March 2021 or March 2022」
The company continues to disclose the structure for stock acquisition rights conditional on operating income exceeding ¥4 billion. Although IFRS operating income for FY2021 was ¥4,030 million, the condition was not deemed to have been met because the exercise condition refers to operating income under Japanese GAAP. - FY2018RaisedAnnual report
「If operating income exceeded ¥4,000 million in any fiscal year ending March 2020, March 2021 or March 2022, holders of the stock acquisition rights could exercise them from the first day of the month following the date of submission of the annual securities report for the first fiscal year in which the condition was met through the final day of the exercise period.」
Although FY2018 EBITDA of ¥3,044 million exceeded the previous ¥2,790 million threshold, the stock acquisition rights issued in February 2018 set a higher performance threshold, requiring operating income to exceed ¥4 billion in any fiscal year ending March 2020 through March 2022. - FY2018-Q2RestatedAnnual report
「If EBITDA for the fiscal year ended March 2018 exceeded ¥2,790 million, holders of the stock acquisition rights could exercise them from the first day of the month following the date of submission of the annual securities report for the fiscal year ended March 2018 through the final day of the exercise period.」
The company continues to disclose the structure for the 695 stock acquisition rights resolved on 19 July 2017, under which exercise is conditional on EBITDA for the fiscal year ended March 2018 exceeding ¥2,790 million. - FY2018-Q1RaisedAnnual report
「If EBITDA for the fiscal year ended March 2018 exceeded ¥2,790 million, holders of the stock acquisition rights could exercise them from the first day of the month following the date of submission of the annual securities report for the fiscal year ended March 2018 through the final day of the exercise period.」
The company resolved to issue 695 new stock acquisition rights for directors of the company and its subsidiaries, raising the EBITDA threshold for exercise from the previous level of over ¥2 billion to over ¥2,790 million. - FY2017AchievedAnnual report
「EBITDA (operating income + depreciation and amortisation + amortisation of goodwill) was ¥2,375 million, up 40.7% year on year.」
EBITDA for the fiscal year ended March 2017 was ¥2.375 billion, exceeding the ¥2 billion threshold for the stock acquisition rights. - FY2017-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
The company actually issued 592 stock acquisition rights for officers and employees. They are exercisable if EBITDA for the fiscal year ended March 2017 exceeds ¥2 billion, with an exercise period from 1 July 2017 to 7 August 2021. - FY2017-Q1First statedAnnual report
「If EBITDA for the fiscal year ended March 2017 exceeded ¥2 billion, holders of the stock acquisition rights could exercise them from the first day of the month following the date of submission of the annual securities report for the fiscal year ended March 2017 through the final day of the exercise period.」
The company announced plans to issue 592 stock acquisition rights to directors of the company and its subsidiaries, exercisable if EBITDA for the fiscal year ended March 2017 exceeded ¥2 billion.